Cargando…
SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184407/ https://www.ncbi.nlm.nih.gov/pubmed/32196087 http://dx.doi.org/10.1093/eurheartj/ehaa235 |
_version_ | 1783526594810216448 |
---|---|
author | Kuster, Gabriela M Pfister, Otmar Burkard, Thilo Zhou, Qian Twerenbold, Raphael Haaf, Philip Widmer, Andreas F Osswald, Stefan |
author_facet | Kuster, Gabriela M Pfister, Otmar Burkard, Thilo Zhou, Qian Twerenbold, Raphael Haaf, Philip Widmer, Andreas F Osswald, Stefan |
author_sort | Kuster, Gabriela M |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7184407 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-71844072020-04-29 SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19? Kuster, Gabriela M Pfister, Otmar Burkard, Thilo Zhou, Qian Twerenbold, Raphael Haaf, Philip Widmer, Andreas F Osswald, Stefan Eur Heart J Viewpoints Oxford University Press 2020-05-14 2020-03-20 /pmc/articles/PMC7184407/ /pubmed/32196087 http://dx.doi.org/10.1093/eurheartj/ehaa235 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Viewpoints Kuster, Gabriela M Pfister, Otmar Burkard, Thilo Zhou, Qian Twerenbold, Raphael Haaf, Philip Widmer, Andreas F Osswald, Stefan SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19? |
title | SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19? |
title_full | SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19? |
title_fullStr | SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19? |
title_full_unstemmed | SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19? |
title_short | SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19? |
title_sort | sars-cov2: should inhibitors of the renin–angiotensin system be withdrawn in patients with covid-19? |
topic | Viewpoints |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184407/ https://www.ncbi.nlm.nih.gov/pubmed/32196087 http://dx.doi.org/10.1093/eurheartj/ehaa235 |
work_keys_str_mv | AT kustergabrielam sarscov2shouldinhibitorsofthereninangiotensinsystembewithdrawninpatientswithcovid19 AT pfisterotmar sarscov2shouldinhibitorsofthereninangiotensinsystembewithdrawninpatientswithcovid19 AT burkardthilo sarscov2shouldinhibitorsofthereninangiotensinsystembewithdrawninpatientswithcovid19 AT zhouqian sarscov2shouldinhibitorsofthereninangiotensinsystembewithdrawninpatientswithcovid19 AT twerenboldraphael sarscov2shouldinhibitorsofthereninangiotensinsystembewithdrawninpatientswithcovid19 AT haafphilip sarscov2shouldinhibitorsofthereninangiotensinsystembewithdrawninpatientswithcovid19 AT widmerandreasf sarscov2shouldinhibitorsofthereninangiotensinsystembewithdrawninpatientswithcovid19 AT osswaldstefan sarscov2shouldinhibitorsofthereninangiotensinsystembewithdrawninpatientswithcovid19 |